efficient transplantation via antibody-based clearance hematopoietic stem cell niches 
upon intravenous transplantation hematopoietic stem cells hscs can home specialized niches yet hscs fail engraft unless recipients subjected toxic preconditioning provide evidence aside immune barriers donor hsc engraftment restricted occupancy appropriate niches host hscs administration ack2 antibody blocks c-kit function led transient removal > % endogenous hscs immunodeficient mice subsequent transplantation mice donor hscs led chimerism levels % extrapolation methods humans may enable mild effective conditioning regimens transplantation 
